Muscle Mass, Ageing, and Weight Management: What You Need to Know

Muscle mass is not just about strength or appearance — it plays a central role in metabolism, blood sugar regulation, and long-term health. From around the age of 30, adults begin to lose muscle mass gradually, a process that accelerates after 60. This age-related muscle loss, known as sarcopenia, has important implications for weight management and overall health.

What is sarcopenia?

Sarcopenia is the progressive loss of skeletal muscle mass and strength that occurs with ageing. The European Working Group on Sarcopenia in Older People (EWGSOP) defines it as low muscle strength combined with low muscle quantity or quality. It is estimated to affect around 10% of adults over 60 and up to 50% of those over 80.

Muscle loss begins earlier than most people realise. Adults typically lose 3–8% of their muscle mass per decade from their thirties, with the rate increasing significantly after 60. This gradual decline can go unnoticed for years, particularly if body weight remains stable — because fat mass often increases as muscle mass falls, keeping the scales unchanged while body composition worsens.

Why does muscle mass matter for weight management?

Skeletal muscle is the body's largest metabolically active tissue. It accounts for a significant proportion of resting energy expenditure — the calories your body burns at rest. As muscle mass declines, resting metabolic rate falls, meaning the body requires fewer calories to maintain weight. This is one reason why weight gain tends to become easier and weight loss harder as people get older, even without changes in diet or activity.

Muscle also plays a key role in glucose metabolism. Skeletal muscle is responsible for approximately 80% of insulin-stimulated glucose uptake. Loss of muscle mass reduces this capacity, increasing the risk of insulin resistance, type 2 diabetes, and metabolic syndrome — all of which are closely linked to excess weight and obesity.

What causes accelerated muscle loss?

Several factors accelerate sarcopenia beyond the normal ageing process:

• Physical inactivity — the most important modifiable factor; even short periods of bed rest cause rapid muscle loss
• Inadequate protein intake — older adults have a higher protein requirement per kilogram of body weight than younger adults, but often consume less
• Obesity — excess fat mass is associated with chronic low-grade inflammation, which promotes muscle protein breakdown
• Rapid weight loss — losing weight quickly, particularly through very low calorie diets, leads to significant loss of lean muscle alongside fat
• Hormonal changes — declining levels of testosterone, oestrogen, and growth hormone with age all contribute to muscle loss
• Chronic illness — conditions such as type 2 diabetes, heart failure, and chronic kidney disease accelerate sarcopenia

Sarcopenic obesity: when muscle loss and excess fat coexist

Sarcopenic obesity — the combination of low muscle mass and excess fat — is increasingly recognised as a distinct and particularly harmful condition. People with sarcopenic obesity have a higher risk of cardiovascular disease, type 2 diabetes, disability, and premature death than those with either condition alone. Importantly, standard BMI measurements do not detect sarcopenic obesity — a person can have a normal or only mildly elevated BMI while having dangerously low muscle mass and high fat mass.

A 2020 meta-analysis in Ageing Research Reviews found that sarcopenic obesity was associated with a 24% higher risk of all-cause mortality compared with obesity alone, and a 41% higher risk compared with sarcopenia alone.

How can muscle loss be prevented or reversed?

The evidence for preserving and building muscle mass is clear:

• Resistance training — the most effective intervention for building and maintaining muscle mass at any age. Two to three sessions per week of progressive resistance exercise produce meaningful gains in muscle mass and strength, even in adults over 80. Exercises can include free weights, resistance machines, resistance bands, or bodyweight exercises.
• Adequate protein intake — current evidence supports a protein intake of 1.2–1.6 g per kilogram of body weight per day for older adults, compared with the standard recommendation of 0.8 g/kg/day. Spreading protein intake across meals — aiming for 25–30 g of high-quality protein per meal — maximises muscle protein synthesis.
• Leucine-rich foods — leucine is an amino acid that directly stimulates muscle protein synthesis. Good sources include meat, fish, eggs, dairy, soya, and legumes.
• Vitamin D — low vitamin D levels are associated with reduced muscle strength and increased fall risk. Supplementation may be beneficial, particularly in older adults with low sun exposure.
• Avoiding rapid weight loss — when weight loss is needed, a moderate calorie deficit combined with high protein intake and resistance training minimises muscle loss.

What does this mean for weight management treatment?

For people using GLP-1 receptor agonists such as Mounjaro or Wegovy, preserving muscle mass during weight loss is an important clinical consideration. These medicines produce significant weight loss, but some of the weight lost may be lean mass. Clinical trials of tirzepatide (Mounjaro) have shown that the proportion of weight lost as fat is higher than with older medicines, but resistance training and adequate protein intake remain important for optimising body composition outcomes.

A doctor-led weight management programme considers body composition alongside weight — not just the number on the scales. Book a consultation with Weight Loss Wales to discuss a personalised approach to weight management.